Implications
The best implication regarding the similarity between the syndrome and insulin resistance is beginning treatment procedure by testing for abnormal blood sugar level. Upon testing positive for insulin resistance, metformin should be a primary medication for the patient. While there is still a possibility that the two disorders are unrelated, it is undeniable that patients are benefiting from metformin. Upon several clinical tests, it would be best if the FDA and other health-relates organizations approve metformin as a treatment. Over time the number of ailing adults may reduce. At any given time, five million adults have the disease and show few signs of recovery.
Final Word
Although there is a missing piece of connection between the chronic syndrome and insulin resistance, studies show that 90% of patients with the disorder show improved clinical outcomes after using insulin resistance treatment. Also, the two diseases have a lot of similarity on brain effects. So far, all the clinical trials using insulin resistance treatment, particularly metformin, have shown positive results only. Though not approved, insulin resistance may be the root cause the syndrome. With that in mind, the percentage of adults having lifetime symptoms will take a turn. This will, in turn, reduce the expenditure of treatment in general, thus lessen the related socioeconomic burden.
